share_log

Raymond James Initiates Coverage On Fulgent Genetics With Outperform Rating, Announces Price Target of $45

Benzinga Real-time News ·  Nov 18, 2022 07:31

Raymond James analyst Andrew Cooper initiates coverage on Fulgent Genetics (NASDAQ:FLGT) with a Outperform rating and announces Price Target of $45.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment